311 related articles for article (PubMed ID: 21933609)
1. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention.
Li XM; Cong HL; Li TT; He LJ; Zhou YJ
Chin Med J (Engl); 2011 Jul; 124(14):2101-6. PubMed ID: 21933609
[TBL] [Abstract][Full Text] [Related]
2. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
[TBL] [Abstract][Full Text] [Related]
3. Comparison of risk factors for contrast-induced acute kidney injury between patients with and without diabetes.
Pakfetrat M; Nikoo MH; Malekmakan L; Tabande M; Roozbeh J; Ganbar Ali RJ; Khajehdehi P
Hemodial Int; 2010 Oct; 14(4):387-92. PubMed ID: 20796046
[TBL] [Abstract][Full Text] [Related]
4. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
5. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
Maschio G; Alberti D; Janin G; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Zucchelli P
N Engl J Med; 1996 Apr; 334(15):939-45. PubMed ID: 8596594
[TBL] [Abstract][Full Text] [Related]
6. Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention.
Andò G; de Gregorio C; Morabito G; Trio O; Saporito F; Oreto G
Circ Cardiovasc Interv; 2014 Aug; 7(4):465-72. PubMed ID: 25027519
[TBL] [Abstract][Full Text] [Related]
7. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
Tasanarong A; Vohakiat A; Hutayanon P; Piyayotai D
Nephrol Dial Transplant; 2013 Feb; 28(2):337-44. PubMed ID: 23314316
[TBL] [Abstract][Full Text] [Related]
8. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.
Morabito S; Pistolesi V; Benedetti G; Di Roma A; Colantonio R; Mancone M; Sardella G; Cibelli L; Ambrosino M; Polistena F; Pierucci A
J Nephrol; 2012; 25(6):1098-107. PubMed ID: 22383347
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention.
Shemirani H; Pourrmoghaddas M
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):280-5. PubMed ID: 22382219
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
[TBL] [Abstract][Full Text] [Related]
11. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
[TBL] [Abstract][Full Text] [Related]
12. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
[TBL] [Abstract][Full Text] [Related]
13. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis.
Maioli M; Toso A; Leoncini M; Gallopin M; Musilli N; Bellandi F
Circulation; 2012 Jun; 125(25):3099-107. PubMed ID: 22592896
[TBL] [Abstract][Full Text] [Related]
14. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
Lee SW; Kim WJ; Kim YH; Park SW; Park DW; Yun SC; Lee JY; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Suh J; Cho YH; Lee NH; Cheong SS; Yoo SY; Lee BK; Lee SG; Hyon MS; Shin WY; Lee SW; Jang JS; Park SJ
Am J Cardiol; 2011 May; 107(10):1447-52. PubMed ID: 21420063
[TBL] [Abstract][Full Text] [Related]
15. Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.
Hoshi T; Sato A; Kakefuda Y; Harunari T; Watabe H; Ojima E; Hiraya D; Abe D; Nishina H; Takeyasu N; Noguchi Y; Aonuma K
Int J Cardiol; 2014 Feb; 171(2):243-9. PubMed ID: 24393575
[TBL] [Abstract][Full Text] [Related]
16. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
17. [The use of recombinant human B-type natriuretic peptide for the protection of cardiac and renal functions in heart failure patients with acute anterior myocardial infarction in peri-operative period of primary percutaneous coronary intervention].
Zhang J; Fu XH; Fan XN; Jia XW; Gu XS; Li SQ; Jiang YF; Fan WZ; Su JL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Nov; 22(11):669-73. PubMed ID: 21122202
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
[TBL] [Abstract][Full Text] [Related]
19. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
[TBL] [Abstract][Full Text] [Related]
20. Long-term impact of mild chronic kidney disease in patients with acute coronary syndrome undergoing percutaneous coronary interventions.
Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Tamura H; Kojima T; Yokoyama K; Kurata T; Daida H
Nephrol Dial Transplant; 2011 Sep; 26(9):2906-11. PubMed ID: 21300704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]